X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
D | 2024-02-16 | CVS | Cvs Health Corp | Shah Prem S | EVP, Pres-Pharm, Consumer W | S - Sale+OE | $76.95 | -29,473 | 77,553 | -28% | -$2,267,947 | |||||
2024-02-07 | COR | Cencora, Inc. | Walgreens Boots Alliance, Inc. | 10% | S - Sale | $235.41 | -4,212,395 | 26,277,561 | -14% | -$991,639,907 | ||||||
2024-01-29 | WBA | Walgreens Boots Alliance, Inc. | Jarrett Valerie B | Dir | P - Purchase | $22.44 | +4,456 | 4,456 | New | +$99,993 | ||||||
2024-01-16 | WBA | Walgreens Boots Alliance, Inc. | Schlichting Nancy M | Dir | S - Sale | $23.05 | -15,209 | 0 | -100% | -$350,567 | ||||||
2024-01-05 | WBA | Walgreens Boots Alliance, Inc. | Wentworth Timothy C | CEO | P - Purchase | $24.22 | +10,000 | 585,122 | +2% | +$242,220 | ||||||
2023-11-10 | WBA | Walgreens Boots Alliance, Inc. | Gates Richard P. | SVP, Chief Pharmacy Officer | S - Sale | $20.45 | -1,000 | 73,929 | -1% | -$20,450 | ||||||
2023-11-09 | PETS | Petmed Express Inc | Fulgoni Gian | Dir | P - Purchase | $7.34 | +41,000 | 117,010 | +54% | +$301,125 | ||||||
2023-11-03 | PETS | Petmed Express Inc | Hulett Mathew N | CEO, Pres | P - Purchase | $7.26 | +13,850 | 613,850 | +2% | +$100,551 | ||||||
2023-11-03 | PETS | Petmed Express Inc | Chambers Christine | CFO | P - Purchase | $7.26 | +6,888 | 19,888 | +53% | +$50,007 | ||||||
D | 2023-11-03 | CVS | Cvs Health Corp | Ludwig Edward J | Dir | P - Purchase | $70.47 | +2,000 | 31,709 | +7% | +$140,930 | |||||
D | 2023-07-01 | RXMD | Progressive Care Inc. | Barreto Rodney | Dir, 10% | S - Sale+OE | $4.39 | -520,999 | 3,581,643 | -13% | -$2,285,076 | |||||
D | 2023-07-01 | RXMD | Progressive Care Inc. | Fernandez Charles M. | COB, CEO, 10% | S - Sale+OE | $4.45 | -600,100 | 3,713,441 | -14% | -$2,670,445 | |||||
D | 2023-09-28 | MDVL | Medavail Holdings, Inc. | Seabaugh Ramona | CFO | S - Sale+OE | $5.70 | -303 | 1,222 | -20% | -$1,726 | |||||
D | 2023-08-03 | ABC | Amerisourcebergen Corp | Walgreens Boots Alliance, Inc. | 10% | S - Sale+OE | $189.27 | -1,320,858 | 31,769,546 | -4% | -$250,000,115 | |||||
D | 2023-08-03 | CVS | Cvs Health Corp | Clark James David | SVP, Cont, Chief Acct Officer | S - Sale+OE | $74.92 | -25,759 | 13,580 | -65% | -$1,930,004 | |||||
2023-06-30 | WBA | Walgreens Boots Alliance, Inc. | Driscoll John Patrick | EVP, Pres U.S. Healthcare | P - Purchase | $28.42 | +5,172 | 59,050 | +10% | +$146,984 | ||||||
D | 2023-05-09 | RXMD | Progressive Care Inc. | Fernandez Charles M. | COB, CEO | P - Purchase | $2.20 | +455,000 | 1,632,633 | +39% | +$1,001,000 | |||||
D | 2023-05-09 | RXMD | Progressive Care Inc. | Barreto Rodney | Dir | P - Purchase | $2.20 | +455,000 | 1,662,633 | +38% | +$1,001,000 | |||||
D | 2023-06-15 | ABC | Amerisourcebergen Corp | Walgreens Boots Alliance, Inc. | 10% | S - Sale+OE | $181.17 | -275,984 | 33,090,404 | -1% | -$50,000,021 | |||||
D | 2023-05-11 | ABC | Amerisourcebergen Corp | Walgreens Boots Alliance, Inc. | 10% | S - Sale+OE | $170.77 | -292,792 | 33,366,388 | -1% | -$50,000,090 | |||||
D | 2023-05-03 | CVS | Cvs Health Corp | Lynch Karen S | Pres, CEO | P - Purchase | $69.75 | +14,000 | 431,392 | +3% | +$976,567 | |||||
2023-03-29 | WBA | Walgreens Boots Alliance, Inc. | Brewer Rosalind G | CEO | P - Purchase | $33.95 | +10,000 | 369,945 | +3% | +$339,510 |
A | Amended filing |
D | Derivative transaction in filing (usually option exercise) |
E | Error detected in filing |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |